[Alpha-blocking activity of raubasine-dihydroergocristine combination in the demedullated rat].
D000317:Adrenergic alpha-Antagonists; D000818:Animals; D004088:Dihydroergotoxine / Q000494:pharmacology*; D004338:Drug Combinations; D006439:Hemodynamics / Q000187:drug effects; D008297:Male; D008526:Medulla Oblongata / Q000502:physiology*; D051381:Rats; D011919:Rats, Inbred Strains; D046948:Secologanin Tryptamine Alkaloids; D015016:Yohimbine / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D004338:Drug Combinations; D046948:Secologanin Tryptamine Alkaloids; D004088:Dihydroergotoxine; D015016:Yohimbine; C005709:raubasine
Etude de l'activité alpha-bloquante d'une association raubasine-dihydroergocristine chez le rat démédullé.